Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

This publication has 19 references indexed in Scilit:

• ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non–ST-Elevation Myocardial Infarction)
  Journal of the American College of Cardiology, 2006
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
  New England Journal of Medicine, 2005
• Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
  The Lancet, 2003
• ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
  Journal of the American College of Cardiology, 2001
• Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
  Annals of Internal Medicine, 1999
• Platelet-Active Drugs
  Chest, 1998
• Oral Anticoagulants
  Chest, 1998
• Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
  Archives of internal medicine (1960), 1994
• Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
  Stroke, 1991
• Atrial Fibrillation: A Major Contributor to Stroke in the Elderly
  Archives of internal medicine (1960), 1987